Overview

Bioequivalence Study of Metformin Hydrochloride 500 mg Film-Coated Tablets in Indonesia Healthy Subject

Status:
Completed
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
The objective of this present study was to investigate whether Glufor® 500 (metformin hydrochloride 500 mg) film-coated tablets manufactured by PT. Pyridam Farma Tbk is bioequivalent to its reference product, Glucophage® 500 mg film-coated tablets manufactured by PT. Merck Tbk, Indonesia under licensed Merck Sante SAS, France.
Phase:
N/A
Details
Lead Sponsor:
PT. Pyridam Farma Tbk
Collaborator:
PT Pharma Metric Labs
Treatments:
Metformin